8-Benzyloxy-3'-deoxy-3'-fluoroguanosine manufacturers
|
| | 8-Benzyloxy-3'-deoxy-3'-fluoroguanosine Basic information |
| Product Name: | 8-Benzyloxy-3'-deoxy-3'-fluoroguanosine | | Synonyms: | 8-Benzyloxy-3'-deoxy-3'-fluoroguanosine;8-Benzyloxy-3’-deoxy-3’-fluoroguanosine;2-amino-8-(benzyloxy)-9-((2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,9-dihydro-6H-purin-6-one | | CAS: | 2389988-61-6 | | MF: | C17H18FN5O5 | | MW: | 391.36 | | EINECS: | | | Product Categories: | | | Mol File: | 2389988-61-6.mol |  |
| | 8-Benzyloxy-3'-deoxy-3'-fluoroguanosine Chemical Properties |
| Boiling point | 735.9±70.0 °C(Predicted) | | density | 1.76±0.1 g/cm3(Predicted) | | pka | 12.40±0.70(Predicted) |
| | 8-Benzyloxy-3'-deoxy-3'-fluoroguanosine Usage And Synthesis |
| Uses | 8-Benzyloxy-3’-deoxy-3’-fluoroguanosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 8-Benzyloxy-3'-deoxy-3'-fluoroguanosine Preparation Products And Raw materials |
|